[Excerpt from the 2025 EASL practice guidelines for the diagnosis and treatment of extrahepatic cholangiocarcinoma]. [PDF]
Shang YW, Han GH.
europepmc +1 more source
[An excerpt of the European Association for the Study of the Liver's clinical practice guidelines on liver vascular diseases in 2025]. [PDF]
Luo BH, Han GH.
europepmc +1 more source
对128例有病理诊断依据的肝细胞场(HCC)、47例慢迁肝(CPH)、105例慢活肝(CAH)、46例肝硬化(LC).采用嵌套式PCR技术检测其血标本中的丙型肝炎病毒(HCv)RNA和乙型肝炎病毒(HBV)DIIA,对这两种病毒的血清学标志也进行了研究。结果:在HCC组。HCVRNA14.1%阳性,HBVDNA7i.3%阳性。CPH,CAH,LC和HCC的HBV感染率均在90%左右,而HCV感染率则分别为8.5%、9.5%、17.4%和19.5%,显示HCV感染率随肝病严重程度的增加而有增加的趋势 ...
doaj
[Research advances on hepatocyte zonal changes in metabolic associated fatty liver disease]. [PDF]
Li Y, Huang ZW, Gan JT, Zhang QF, Fu WW.
europepmc +1 more source
[Research progress on the effects of time-restricted eating on metabolic associated fatty liver disease]. [PDF]
Jiang ZQ, Wei TJ, Li GX.
europepmc +1 more source
[A review of research progress in integrated traditional Chinese and Western Medicine for liver diseases]. [PDF]
Zhang Q +6 more
europepmc +1 more source
[Introduction to the recommendations of the EASL clinical practice guidelines for genetic cholestatic liver diseases]. [PDF]
Hou W, Zheng SJ.
europepmc +1 more source
[Periodontitis and Metabolic Dysfunction-Associated Fatty Liver Disease: From Oral Dysbiosis to Hepatic Metabolic Dysregulation]. [PDF]
Wang M +5 more
europepmc +1 more source
[Recommendations from the European Association for the Study of the Liver and the European Reference Network for Rare Liver Diseases Clinical Practice Guidelines for hepatolenticular degeneration]. [PDF]
Tang S, Hou W, Zheng SJ.
europepmc +1 more source
[Inherited metabolic liver disease causing copper deposition]. [PDF]
Jiang H, Liang C, Liu H, Zheng SJ.
europepmc +1 more source

